Delivery Order SPE2DB22D2009-SPE2DB24FM0UM

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a diabetes medication, with a ceiling value of $1,425.76 and a period of performance through May 5, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a medication used to treat diabetes. The contract has a ceiling value of $1,022.80 and runs through February 11, 2025. The contract is a firm fixed-price, delivery order contract with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a diabetes medication, with a ceiling value of $2,435.10 and a performance period through May 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,476.26, is for the supply of Lantus SoloStar 100 Unit/mL 3mL, a diabetes medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00. The IDC provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,046.82 firm fixed-price contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a diabetes medication. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, to support federal healthcare requirements. The contract has a ceiling value of $2,073.72 and a performance period through June 23, 2025. It is a firm fixed price contract, with no set-aside designation, indicating open...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a diabetes medication. The contract has a ceiling value of $1,578.19 and is a firm fixed price delivery order contract. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,132.89, is for the supply of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used primarily for the treatment of diabetes. The delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used for the treatment of diabetes. The contract has a ceiling value of $1,190.92 and a completion date of February 27, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $5,955.31 and a performance period through May 23, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FM0UM
    Delivery Order

This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract has a ceiling value of $6,371.46 and a period of performance through July 15, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:50 AM